Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation
- PMID: 20185054
- PMCID: PMC3057430
- DOI: 10.1016/j.jacc.2010.01.001
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation
Figures
Comment in
-
Macroscopic T-wave alternans: the tip of the iceberg in drug-induced torsade de pointes?J Am Coll Cardiol. 2010 Jul 13;56(3):241; author reply 241-2. doi: 10.1016/j.jacc.2010.03.041. J Am Coll Cardiol. 2010. PMID: 20620750 No abstract available.
References
-
- Dessertenne F. La tachycardie ventriculaire á deux foyers opposes variables. Arch Mal Coeur Vaiss. 1966;59:263–72. - PubMed
-
- Kay GN, Plumb VJ, Arciniegas JG, Henthorn RW, Waldo AL. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. J Am Coll Cardiol. 1983;2:806–17. - PubMed
-
- Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:1136–44. - PubMed
-
- Zareba W, Moss AJ, Schwartz PJ, et al. Influence of genotype on the clinical course of the long-QT syndrome: International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998;339:960–5. - PubMed
-
- Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348:1866–74. - PubMed
